Low “quotient” Lp(a) Concentration Mediates Autoimmune Activation and Independently Predicts Cardiometabolic Risk

Abstract

Elevated cardiometabolic risk is conferred by apparently reduced circulating Lp(a) assays supporting the notion that "low" serum Lp(a), mediating autoimmune activation, is a major determinant of cardiometabolic risk.